XTSX
NEWU
Market cap9mUSD
Jan 10, Last price
0.01CAD
Name
Newtopia Inc
Chart & performance
P/E
—
P/S
0.09
EPS
—
Vol. 1Y
—
Shs. 5Y
10.38%
Rev. 5Y
26.06%
Div Yld LY
—
Div Yld TTM
—
Revenues
10m
-12.38%
Net income
-7m
L-14.29%
CFO
-2m
L-61.63%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Newtopia Inc. operates as a health technology enterprise, concentrating its efforts on delivering effective strategies to avert illness. The firm provides a bespoke platform aimed at helping individuals modify their behaviors, ultimately working to lower both physical and psychological health hazards. Founded in 2008, its primary business operations are managed from its headquarters in Toronto, Canada.
Key people
Jeffrey Ruby
Chief Executive Officer, Founder, Director · since 2019
Collin Swenson
Chief Financial Officer · since 2022
Lara Dodo
Chief Operating Officer, Chief Growth Officer
Mark Jackson
Senior Vice President - Commercial
Bill Wyck
Chief Technology Officer, Head of Product
Peter Seider
Chief Information Officer, Privacy and Security Officer
Barclay Jackson
Senior Marketing Office
Natasha Vani
Director - Exercise and Nutrition · since 2019
Independent Director · since 2020
Carleen Hawn
Independent Director · since 2020
Michael Palmer
Independent Director · since 2020
Roger Poirier
Independent Director · since 2021
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||